The pharmacoeconomics of biologic therapy for IBD.

Nature Reviews. Gastroenterology & Hepatology
Russell D Cohen

Abstract

The past decade has been marked by the introduction and expanding use of biologic therapies for the induction and maintenance of response in patients with IBD. Although widely heralded for their efficacy, these agents have also stirred controversy over the potential economic impact that they will have upon the world's health-care systems. Traditional cost analyses had shown that IBD medication costs contributed minimally towards the overall costs associated with the disease; however, these studies were all conducted before the introduction of biologic therapies. At that time, a small minority of patients accounted for a disproportionately large percentage of the overall costs, suggesting that cost-savings could be realized if interventions decreased the utilization of health-care resources and associated costs. More recent studies have been heterogeneous in their design and findings-some have suggested that cost-savings realized due to a decrease in the utilization of health-care services may offset the higher costs of biologic agents. Incorporation of data on indirect cost-savings and quality of life improvements into ongoing and future analyses is required to allow for more accurate analyses of overall costs and cost-savings.

References

Jun 1, 1992·Journal of Clinical Gastroenterology·J W Hay, A R Hay
Jun 1, 1992·Journal of Clinical Gastroenterology·A R Hay, J W Hay
Oct 1, 1990·Gastroenterology·P RutgeertsM Hiele
Dec 1, 1986·Diseases of the Colon and Rectum·A Sonnenberg
Jan 1, 1994·Alimentary Pharmacology & Therapeutics·R Arnold
Dec 17, 1997·Scandinavian Journal of Gastroenterology·P Blomqvist, A Ekbom
Feb 24, 2000·The American Journal of Gastroenterology·R D CohenL L Mummert
Mar 10, 2000·The American Journal of Gastroenterology·C N BernsteinJ F Blanchard
Aug 19, 2000·The American Journal of Gastroenterology·B G FeaganM V Bala
May 29, 2001·Gastroenterology·K O ArseneauA F Connors
Oct 19, 2001·Gastroenterology·F S Huang, B W Warner
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Aug 13, 2002·Journal of Clinical Gastroenterology·Joel H RubensteinRussell D Cohen
Jan 11, 2003·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Robert Hilsden
Jan 11, 2003·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Steven Lewis
Jan 11, 2003·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Craig R Mitton, UNKNOWN Canadian Coordinating Office for Health Technology Assessment
Feb 6, 2004·Gastroenterology·Paul RutgeertsStephen B Hanauer
Feb 24, 2004·Gastroenterology·Ananias C Diokno
Feb 27, 2004·The New England Journal of Medicine·Bruce E SandsSander J van Deventer
Sep 28, 2004·International Journal of Technology Assessment in Health Care·Isabelle Jaisson-HotCyrille Colin
Nov 13, 2004·Gastroenterology·Amethyst C Kurbegov, Saul J Karpen
Dec 4, 2004·Gastroenterology·Yaron Niv
Apr 9, 2005·Journal of Clinical Gastroenterology·Brian G FeaganStephen Hanauer
Sep 9, 2005·European Journal of Gastroenterology & Hepatology·Derek P JewellScot Buchan

❮ Previous
Next ❯

Citations

Aug 10, 2011·Inflammatory Bowel Diseases·Seth D CrockettMichael D Kappelman
Sep 25, 2012·World Journal of Gastroenterology : WJG·Alan B R ThomsonHugh J Freeman
Jul 9, 2014·Journal of Crohn's & Colitis·Katharina BüschJonas F Ludvigsson
Jan 19, 2011·Journal of Internal Medicine·O H NielsenG Rogler
Jul 31, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Michael EberhardsonOla Winqvist
Nov 13, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·José L TlaxcaMichael B Lawrence
Feb 1, 2017·Proceedings of the National Academy of Sciences of the United States of America·Emre TurerBruce Beutler
Feb 8, 2018·Alimentary Pharmacology & Therapeutics·S BallouA Lembo
Dec 15, 2010·Nature Reviews. Immunology·Maya Saleh, Giorgio Trinchieri
May 1, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wei-Ching HuangSarah Spiegel
Oct 23, 2012·Digestive Diseases and Sciences·Christian D Stone
Feb 26, 2020·Cellular & Molecular Immunology·Qiaoshi LianBing Sun
Apr 27, 2019·Expert Review of Gastroenterology & Hepatology·Nicole LopezWillam J Sandborn
Nov 17, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Paul B ShynStuart G Silverman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.